Recruiting TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers. NCT07009184 Conditions HER2 Positive Solid Tumor Locations Radboud University Medical Center — Nijmegen, Gelderland, Netherlands View Trial Details
Not Yet Recruiting An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy NCT07631871 Conditions Adnexal Diseases, CERVICAL NEOPLASMS, Carcinoma, +38 more Locations Not specified View Trial Details
Completed KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor NCT04040699 Conditions HER2 Positive Solid Tumor Locations Beijing Cancer Hospital — Beijing, Beijing Municipality, China View Trial Details
